Accès à distance ? S'identifier sur le proxy UCLouvain
Phase 2 randomised trial of oral C5A receptor antagonist CCX168 in ANCA-associated renal vasculitis
Primary tabs
| Document type | Communication à un colloque (Conference Paper) – Abstract |
|---|---|
| Access type | Accès restreint |
| Publication date | 2014 |
| Language | Anglais |
| Conference | "51ST ERA-EDTA CONGRESS", Amsterdam (du 31/05/2014 au 03/06/2014) |
| Journal information | "Nephrology, Dialysis, Transplantation" - Vol. 29, no.suppl 3, p. iii27 (2014) |
| Peer reviewed | yes |
| issn | 0931-0509 |
| e-issn | 1460-2385 |
| Publisher | Oxford University Press ((United Kingdom) Oxford) |
| Publication status | Publié |
| Affiliations |
UCL
- SSS/IREC/NEFR - Pôle de Néphrologie UCL - (SLuc) Service de néphrologie |
| Links |
| Bibliographic reference | Jayne, D. R. W. ; Bruchfeld, A. ; Schaier, M. ; Ciechanowski, K. ; Harper, L. ; et. al. Phase 2 randomised trial of oral C5A receptor antagonist CCX168 in ANCA-associated renal vasculitis.51ST ERA-EDTA CONGRESS (Amsterdam, du 31/05/2014 au 03/06/2014). In: Nephrology, Dialysis, Transplantation, Vol. 29, no.suppl 3, p. iii27 (2014) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/150608 |